Elsevier

Gene

Volume 769, 15 February 2021, 145172
Gene

Research paper
Quercetin regulates ERα mediated differentiation of BMSCs through circular RNA

https://doi.org/10.1016/j.gene.2020.145172Get rights and content

Highlights

  • 136 circRNA expression profiles alternated in the Lv-shERα group, and 120 in the Lv-shERα + QUE group.

  • QUE moderated the osteogenic and adipogenic differentiation of BMSCs aroused by ERα deficiency.

  • ERα and QUE regulate the differentiation of rBMSCs through the circRNA–miR-326-5p–mRNA axis.

Abstract

Circular RNA (circRNA) participates in regulation of gene transcription, while estrogen receptor alpha (ERα) and quercetin (QUE) positively regulate bone formation, but little is known about the correlation among circRNA, ERα and QUE. In this experiment, we created an ERα-deficient rBMSC model treated with QUE and evaluated the effects of ERα or QUE on rBMSCs, then analyzed differentially-expressed circRNAs by RNA-Seq and bioinformatics. The results showed that ERα deficiency constrained osteogenic differentiation and stimulated adipocytic differentiation of rBMSCs, while QUE abrogated those effects. We identified 136 differentially-expressed circRNAs in the Lv-shERα group and 120 differentially-expressed circRNAs in the Lv-shERα + QUE group. Thirty-two circRNAs retroregulated by ERα and QUE were involved in Rap1 and Wnt signaling, and four of them together sponged miR-326-5p, the target genes of which are osteogenic and adipogenic differentiation factors. Further study showed that over-expressed miR-326-5p could stimulate osteogenic differentiation, while attenuating adipogenic differentiation of rBMSCs. Therefore, we concluded that ERα and QUE might regulate the differentiation of rBMSCs through the circRNA–miR-326-5p–mRNA axis.

Introduction

Bone mesenchymal stem cells (BMSCs) have the characteristic of multipotential differentiation. Meanwhile, the equilibrium state between osteoblasts and adipocytes is closely related to the occurrence of bone metabolic disorders such as osteoporosis (OP) (Kolf et al., 2007). These processes are influenced by a variety of factors, including age, secretion of hormones and cytokines and so on. A decrease or deficiency in estrogen secretion is the core reason for the high risk of OP in postmenopausal women (Passos-Soares et al., 2017). Estrogen ligands mainly comprise estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ). Interestingly, ERα has a more important regulatory function in bone metabolism than ERβ, being essential for the strain-related response in osteoblast lineage cells (Lee et al., 2003). Iravani et al. (2017) identified ERα as the main mediator of estrogenic effects on bone growth and maturation. Furthermore, ERα is more important than ERβ in fracture healing induced by vibration (Iravani et al., 2017). Therefore, ERα plays a greater role in regulating the osteogenic differentiation of rBMSCs.

Circular RNA (circRNA) belongs to the class of non-coding RNAs, and there is emerging evidence that multifarious circRNAs participate in various essential life processes, as well as being closely related to the occurrence of bone metabolic disease (Huang et al., 2019). Long et al. (2018) demonstrated that 43 circRNAs are differentially expressed in the process of osteogenic differentiation of mouse adipose-derived stromal cells. CircRNA.33186 is differentially expressed in destabilized medial meniscus-induced osteoarthritis, and is sponged by miR-127-5p to regulate the proliferation and apoptosis of chondrocytes (Zhou et al., 2019). Yu and Liu (2019) compared the expression of circRNAs and miRNAs in postmenopausal osteoporosis patients and healthy people, and they concluded that circ_0016624 sponged miR-98 to facilitate the progression of osteoporosis. Therefore, we wondered whether circRNAs play a crucial role in the process of rBMSC differentiation.

Quercetin (QUE) is a class of flavone, which is extracted from rutin. As the structure and bioactivity of QUE is similar to estrogen, it is viewed as a phytoestrogen. The antioxidant effects of QUE have been known for many years (Kawabata et al., 2015), while its anti-osteoporotic effect was identified more recently (Rayalam et al., 2011). Experiments in vivo and in vitro both revealed that QUE stimulates angiogenesis and osteogenesis, and inhibits osteoclastogenesis under different osteoporotic conditions (Orsolic et al., 2018, Zhou et al., 2017). Furthermore, QUE influences the direction of differentiation of human MSCs via Wnt/beta-catenin signaling (Casado-Diaz et al., 2016). Pang et al. (Pang et al., 2018) proved that QUE mediates the osteogenic differentiation of rBMSCs through ER signaling. Hence, we wanted to know whether QUE could regulate differentiation in ERα-deficient rBMSCs and if so, what mechanism is involved.

In this study, we constructed an ERα-deficient rBMSC model, and treated it with QUE, to explore the effects of QUE on the direction of differentiation in ERα-deficient rBMSCs. We then compared the differentially-expressed circRNAs involved in these processes, to analyze the correlation among the ERα, circRNAs, QUE and the differentiation of rBMSCs, in an effort to identify future therapeutic targets of bone metabolism, which may provide a new approach to prevent and cure bone metabolic diseases.

Section snippets

Culture of rBMSCs

rBMSCs (RASMX-01001, Cyagen Biosciences Inc., Guangzhou, China) were cultured in alpha-MEM (Gibco, Life Technologies, Carlsbad, CA, USA) containing 10% fetal bovine serum (Ausgenex Pty, Molindar, Queensland, Australia), in a humidified chamber with 5% CO2 at 37 °C.

Transfection of rBMSCs

rBMSCs were inoculated into 6-well plates and cultured until they reached 50–60% confluence, then transfected with a plasmid carrying a green fluorescent reporter gene using lentivirus (VB160812-1065yvh, Cyagen, China) at a

Effects of different concentrations of QUE on rBMSC viability and osteogenic differentiation

We used the CCK-8 assay to evaluate cell viability at 24 and 48 h. Compared with the CON group, the concentration of 10−4 mM QUE significantly inhibited cell viability at 48 h (*P < 0.05); in contrast, the other treatment groups were not significantly different from the CON group at 24 or 48 h (Fig. 1a).

ALP is an enzyme secreted by osteoblasts and used as a marker of osteogenic differentiation. We used an ALP assay kit to evaluate the osteogenic differentiation ability of rBMSCs. The results

Discussion

The balance between osteogenic and adipogenic differentiation of rBMSCs is strongly associated with the occurrence of bone metabolic disorders. Research has indicated that a number of factors influence this process, such as the secretion of hormones, cytokines, and other age-related factors (Infante and Rodriguez, 2018, Sbrana et al., 2016). Postmenopausal women have a high risk of osteoporosis, caused by a decrease in the amount of estrogen or insufficient secretion (Passos-Soares et al., 2017

Conclusion

Our study demonstrates that QUE regulates the osteogenic and adipocytic differentiation of ERα-deficient rBMSCs. We proved that ERα and QUE regulate the differentiation of rBMSCs through regulating expression of some circRNAs, and after constructing the network, we found that the circRNA–miR-326-5p–mRNA axis might play a vital role in the process of osteogenic differentiation in rBMSCs. Our study may provide a new mechanism via which ERα mediates the differentiation of rBMSCs, as well as

CRediT authorship contribution statement

Xiaoyun Li: Investigation, Methodology, Data curation, Writing - original draft. Rumeng Chen: Investigation, Methodology, Data curation, Writing - original draft. Xiaotong Lei: Software, Validation, Visualization. Panpan Wang: Software, Validation, Visualization. Xiaofeng Zhu: Software, Validation, Visualization. Ronghua Zhang: Funding acquisition, Project administration, Supervision, Resources, Writing - review & editing. Li Yang: Funding acquisition, Project administration, Supervision,

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgments

This work was sponsored by the National Natural Science Foundation of China (grant no. 81873202 and 81673837), the National Natural Fund Youth Science Fund Project (no. 81503384), and National Key R&D Program of China (no. 2018YFC2002500). We also thank the Cancer Research Institution of Jinan University for their contributions.

Data available

The data used to support the findings of this experiment are available from the corresponding author upon request.

References (27)

  • X. Huang et al.

    Prospect of circular RNA in osteogenesis: a novel orchestrator of signaling pathways

    J. Cell. Physiol.

    (2019)
  • A. Infante et al.

    Osteogenesis and aging: lessons from mesenchymal stem cells

    Stem Cell Res. Ther.

    (2018)
  • M. Iravani et al.

    Regulation of bone growth via ligand-specific activation of estrogen receptor alpha

    J. Endocrinol.

    (2017)
  • Cited by (9)

    • Regulation of Wnt signaling by non-coding RNAs during osteoblast differentiation

      2022, Differentiation
      Citation Excerpt :

      Overexpression of miR-326-5p stimulated osteogenic differentiation in rBMSCs while suppressing adipogenic differentiation. As a result, it was hypothesized that ER and QUE might influence rBMSC development via the circRNA/miR-326-5p/mRNA axis (Li et al., 2021). Another study reported an elevated level of circ_MYO10 in OS cell lines and tissues.

    • Regulatory roles of phytochemicals on circular RNAs in cancer and other chronic diseases

      2021, Pharmacological Research
      Citation Excerpt :

      Recent study found 120 differentially expressed circRNAs after 0.1 μM quercetin treatment in OP models, and 4 of them sponged miR-326-5p. Further experiments shown that miR-326-5p over-expression could stimulate the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) and weaken adipogenic differentiation, thus influencing the metabolism of bone marrow mesenchymal stem cells (BMSCs) [123]. Consequently, quercetin might treat OP by regulating the abnormally expressed circRNAs.

    View all citing articles on Scopus
    1

    These authors contributed equally to this work.

    View full text